We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+52.12%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$2.58B
AUM Growth
+$1.06B
Cap. Flow
+$1.07B
Cap. Flow %
41.35%
Top 10 Hldgs %
67.03%
Holding
812
New
224
Increased
195
Reduced
131
Closed
143

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$211M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
META icon
Meta Platforms (Facebook)
META
+$111M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$42.4M
5
AAPL icon
Apple
AAPL
+$35.7M

Top Sells

Rank Stock Value
1
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$33M
2
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$30.3M
3
IMCR icon
Immunocore
IMCR
+$28.5M
4
SIRI icon
SiriusXM
SIRI
+$26.6M
5
IMO icon
Imperial Oil
IMO
+$24.7M

Sector Composition

Rank Sector Weight
1 Financials 29.84%
2 Technology 29.38%
3 Healthcare 23.72%
4 Communication Services 6.1%
5 Energy 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
676
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-1,642,347
Closed -$23.2M
BBIO icon
677
BridgeBio Pharma
BBIO
$16.6B
– –
-72,141
Closed -$2.91M
BHVN icon
678
Biohaven
BHVN
$2.12B
– –
-78,319
Closed -$3.35M
BIIB icon
679
Biogen
BIIB
$30.3B
– –
-3,326
Closed -$861K
BMRN icon
680
BioMarin Pharmaceuticals
BMRN
$13.4B
– –
-22,865
Closed -$2.2M
BPMC
681
DELISTED
Blueprint Medicines
BPMC
– –
-38,353
Closed -$3.54M
BTM
682
DELISTED
Bitcoin Depot
BTM
– –
-1,429
Closed -$32.3K
BYND icon
683
Beyond Meat
BYND
$212M
– –
-70,000
Closed -$623K
CDLR icon
684
Cadeler
CDLR
$2.24B
– –
-85,131
Closed -$1.57M
CLBR.U
685
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
– –
-490,829
Closed -$4.95M
CMI icon
686
Cummins
CMI
$87.6B
– –
-3,500
Closed -$838K
CRESW
687
DELISTED
Cresud SACIF y A. Warrant
CRESW
– –
-3,034,316
Closed -$2.28M
CREVW
688
DELISTED
Carbon Revolution PLC Warrant
CREVW
– –
-30,000
Closed -$1.65K
CYTK icon
689
Cytokinetics
CYTK
$10.8B
– –
-56,828
Closed -$4.4M
EOSE icon
690
Eos Energy Enterprises
EOSE
$1.51B
– –
-75,000
Closed -$81.8K
EXEL icon
691
Exelixis
EXEL
$12.9B
– –
-92,654
Closed -$2.06M
HALO icon
692
Halozyme
HALO
$11.7B
– –
-54,034
Closed -$2M
IMO icon
693
Imperial Oil
IMO
$62.8B
– –
-433,016
Closed -$24.7M
IMUX icon
694
Immunic
IMUX
$202M
– –
-31,706
Closed -$476K
IMVT icon
695
Immunovant
IMVT
$8.33B
– –
-69,410
Closed -$2.92M
IONS icon
696
Ionis Pharmaceuticals
IONS
$9.34B
– –
-51,415
Closed -$2.6M
IPG
697
DELISTED
Interpublic Group of Companies
IPG
– –
-26,676
Closed -$871K
IRWD icon
698
Ironwood Pharmaceuticals
IRWD
$699M
– –
-200,578
Closed -$2.43M
JSPR icon
699
Jasper Therapeutics
JSPR
$32M
– –
-20,000
Closed -$158K
KRYS icon
700
Krystal Biotech
KRYS
$9.8B
– –
-16,634
Closed -$2.06M
26 27
28
29 30

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2024 Portfolio in Review

As of Q1 2024, Cowen and Company held 812 positions worth $2.58B, up 69% from $1.52B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $1.07B of net new capital in Q1 2024, opening 224 new positions and adding to 195 existing holdings. Its largest new stake was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, an estimated $30.3M trimmed.

  • Cowen and Company's largest Q1 2024 buy was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.
  • Cowen and Company added most to Coinbase in Q1 2024, an estimated $211M increase.
  • Cowen and Company's biggest Q1 2024 reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, cutting an estimated $30.3M.
  • Cowen and Company fully exited State Street Energy Select Sector SPDR ETF in Q1 2024, selling an estimated $33M.
  • Cowen and Company's ten largest holdings make up 67% of its $2.58B portfolio in Q1 2024.
  • Cowen and Company opened 224 new positions and closed 143 in Q1 2024.
  • Cowen and Company's portfolio value rose 69% quarter-over-quarter to $2.58B.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.